ReviewLancet (London, England)2019
Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
Abstract readReview
In one paragraph
Review in Lancet (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 201 papers, 4 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
201citing papers in PubMed, 4 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
201 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Anemia burden in tuberculosis patients across Southeast Asia: a systematic review and meta-analysis.BMC pulmonary medicine · 2026Pooled it
- Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions.PLoS medicine · 2023Pooled it
- The relationship between mental health and risk of active tuberculosis: a systematic review.BMJ open · 2022Pooled it
- The prevalence of tuberculosis infection in India: A systematic review and meta-analysis.The Indian journal of medical researchPooled it
- Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial.The Lancet. Child & adolescent health · 2023Trial
- Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.PLoS medicine · 2021Trial
- Sequential non-invasive following short-term invasive mechanical ventilation in the treatment of tuberculosis with respiratory failure: a randomized controlled study.BMC pulmonary medicine · 2021Trial
- Trial
- Article
- Global, regional, and national economic value of reducing amenable tuberculosis mortality.Infectious Disease Modelling · 2026Article
- Structural Prediction and Functional Mechanistic Characterization of Farnesyl Diphosphate Synthase fromACS omega · 2026Article
- Risk factors of multi-drug-resistant tuberculosis among tuberculosis patients in Bagmati Province, Nepal: a matched case-control study.BMC infectious diseases · 2026Article
- Partial evaluation of fidelity in the implementation of tuberculosis preventive treatment in people living with HIV in Paraguay: an implementation science study.Revista peruana de medicina experimental y salud publica · 2026Observational
- Epidemiological trajectories and predictive modeling of latent tuberculosis prevalence in South Asia: an in-depth global burden of disease analysis (1990-2021) with advanced forecasting to 2050.Journal of clinical tuberculosis and other mycobacterial diseases · 2026Article
- Development and validation of a machine learning model for community-based tuberculosis screening among persons aged ≥ 15 years in South Africa and Zambia.medRxiv : the preprint server for health sciences · 2026Article
- Challenges and Opportunities for Improved Tuberculosis and HIV Prevention in South America.Open forum infectious diseases · 2026Review
- Resolving the vertical versus horizontal conundrum: the potential of a "next generation" community health worker program to accelerate progress in TB control and at the same time strengthen primary health care.Frontiers in public health · 2026Article
- Functional and mechanistic characterization of the phosphatidyl-Frontiers in cellular and infection microbiology · 2026Article
- Bayesian networks for predicting clinical outcomes in COVID-19 patients: A retrospective study in a resource-limited setting.PloS one · 2026Article
- Tuberculosis and tuberculosis-human immunodeficiency virus in post-conflict West Africa: Lessons for integrated surveillance from 2000 to 2022.Journal of public health in Africa · 2026Article
141 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
77 authors.
Michael J A ReidDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: michael.reid2@ucsf.edu.
Nimalan ArinaminpathySchool of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK.
Amy BloomTuberculosis Division, United States Agency for International Development, Washington, DC, USA.
Barry R BloomDepartment of Global Health and Population, Harvard University, Cambridge, MA, USA.
Catharina BoehmeFoundation for Innovative New Diagnostics, Geneva, Switzerland.
Richard ChaissonDepartments of Medicine, Epidemiology, and International Health, Johns Hopkins School of Medicine, Baltimore, MA, USA.
Daniel P ChinBill & Melinda Gates Foundation, Seattle, WA, USA.
Gavin ChurchyardThe Aurum Institute, Johannesburg, South Africa.
Helen CoxDepartment of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Lucica DitiuStop TB Partnership, Geneva, Switzerland.
Mark DybulDepartment of Medicine, Centre for Global Health and Quality, Georgetown University, Washington, DC, USA.
Jeremy FarrarThe Wellcome Trust, London, UK.
Anthony S FauciNational Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA.
Endalkachew FekaduVolunteer Health Services, Addis Ababa, Ethiopia.
Paula I FujiwaraDepartment of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France.
Timothy B HallettSchool of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK.
Christy L HansonBill & Melinda Gates Foundation, Seattle, WA, USA.
Mark HarringtonTreatment Action Group, New York, NY, USA.
Nick HerbertGlobal TB Caucus, Houses of Parliament, London, UK.
Philip C HopewellDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Chieko IkedaDepartment of GLobal Health, Ministry of Heath, Labor and Welfare, Tokyo, Japan.
Dean T JamisonDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
Aamir J KhanInteractive Research & Development, Karachi, Pakistan.
Irene KoekGlobal Health Bureau, United States Agency for International Development, Washington, DC, USA.
Nalini KrishnanResource Group for Education and Advocacy for Community Health, Chennai, India.
Aaron MotsoalediSouth African National Department of Health, Pretoria, South Africa.
Madhukar PaiDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada.
Mario C RaviglioneUniversity of Milan, Milan, Italy; Global Studies Institute, University of Geneva, Geneva, Switzerland.
Almaz SharmanAcademy of Preventive Medicine of Kazakhstan, Almaty, Kazakhstan.
Peter M SmallGlobal Health Institute, School of Medicine, Stony Brook University, Stony Brook, NY, USA.
Soumya SwaminathanWHO, Geneva, Switzerland.
Zelalem TemesgenDepartment of Infectious Diseases, Mayo Clinic, Rochester, MI, USA.
Anna VassallDepartment of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK; Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands.
Nandita VenkatesanThe Economic Times, Mumbai, India.
Kitty van WeezenbeekKNCV Tuberculosis Foundation, The Haag, Netherlands.
Gavin YameyCenter for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA.
Bruce D AginsDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Sofia AlexandruInstitutul de Ftiziopneumologie Chiril Draganiuc, Chisinau, Moldova.
Jason R AndrewsDivision of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA.
Naomi BeyelerInstitute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
Stela BivolCenter for Health Policies and Studies, Chisinau, Moldova.
Grania BrigdenDepartment of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France.
Adithya CattamanchiDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Danielle CazabonMcGill International TB Center, McGill University, Montreal, QC, Canada.
Valeriu CruduCenter for Health Policies and Studies, Chisinau, Moldova.
Amrita DaftaryDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada.
Puneet DewanBill & Melinda Gates Foundation, New Delhi, India.
Laurie K DoepelNational Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA.
Robert W EisingerNational Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA.
Victoria FanT H Chan School of Public Health, Harvard University, Cambridge, MA, USA; Office of Public Health Studies, University of Hawaii, Mānoa, HI, USA.
Sara FewerInstitute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
Jennifer FurinDivision of Infectious Diseases & HIV Medicine, Case Western Reserve University, Cleveland, OH, USA.
Jeremy D Goldhaber-FiebertCenters for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA.
Gabriela B GomezDepartment of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Stephen M GrahamDepartment of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Paediatrics, Center for International Child Health, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia.
Devesh GuptaRevised National TB Control Program, New Delhi, India.
Maureen KameneNational Tuberculosis, Leprosy and Lung Disease Program, Ministry of Health, Nairobi, Kenya.
Sunil KhapardeGeneral TB control, New Delhi, India.
Eunice W MailuNational Tuberculosis, Leprosy and Lung Disease Program, Ministry of Health, Nairobi, Kenya.
Enos O MasiniWHO, Nairobi, Kenya.
Lorrie McHughOffice of the Secretary-General's Special Envoy on Tuberculosis, United Nations, Geneva, Switzerland.
Ellen MitchellInternational Institute of Social Studies, Erasmus University Rotterdam, The Hague, Netherland.
Suerie MoonDepartment of Global Health and Population, Harvard University, Cambridge, MA, USA; Global Health Centre, The Graduate Institute Geneva, Geneva, Switzerland.
Michael OsbergLinksbridge, Seattle, WA, USA.
Tripti PandeMcGill International TB Center, McGill University, Montreal, QC, Canada.
Lea PrinceCenters for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA.
Kirankumar RadeCentral Tuberculosis Division, WHO, New Delhi, India.
Raghuram RaoMinistry of Health and Family Welfare, New Delhi, India.
Michelle RemmeInternational Institute for Global Health, United Nations University, Kuala Lumpur, Malaysia.
James A SeddonDepartment of Medicine, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK; Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa.
Casey SelwynBill & Melinda Gates Foundation, Seattle, WA, USA.
Priya SheteDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Kuldeep S SachdevaRevised National TB Control Program, New Delhi, India.
Guy StallworthySeattle, WA, USA.
Juan F VesgaSchool of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK.
Valentina VilcNational TB Program, WHO, Chisinau, Moldova.
Eric P GoosbyDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
Funding
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0MMedical Research Council MR/R007942/1Medical Research Council MR/R015600/1NIAID NIH HHS P30 AI094189World Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
Cost of IllnessDisease EradicationGlobal HealthGoalsHealth PolicyHealth PrioritiesHumansIncidenceLeadershipMortalityMycobacterium tuberculosisPolitical SystemsQuality of Health CareResearchTuberculosis, PulmonaryWorld Health Organization
Identifiers
PMID
30904263What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.